Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation

Authors:	Erica D. Warlick MD Celalettin Ustun MD Astrid Andreescu MD Anthony F. Bonagura MD Andrew Brunner MD Abhinav B. Chandra MD James M. Foran MD Mark B. Juckett MD Tamila L. Kindwall-Keller DO Virginia M. Klimek MD Daniel F. Pease MD David P. Steensma MD Bryce M. Waldman Mary M. Horowitz MD MS Linda J. Burns MD Nandita Khera MD MPH

Affiliation:	1. Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota;2. Rush University Medical Center, Chicago, Illinois;3. Northern Light Eastern Maine Medical Center, Lafayette Family Cancer Institute, Bangor, Maine;4. Optum, North Wales, Pennsylvania;5. Massachusetts General Hospital, Boston, Massachusetts;6. Yuma Regional Medical Center, Yuma, Arizona;7. Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, Florida;8. School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin;9. University of Virginia, Charlottesville, Virginia;10. Memorial Sloan Kettering Cancer Center, New York, New York;11. Hennepin Healthcare, Minneapolis, Minnesota;12. Dana-Farber Cancer Institute, Boston, Massachusetts;13. Center for International Blood and Marrow Transplant, Milwaukee, Wisconsin;14. Center for International Blood and Marrow Transplant, Milwaukee, Wisconsin Medical College of Wisconsin, Milwaukee, Wisconsin;15. College of Medicine, Mayo Clinic, Phoenix, Arizona

Abstract:

Keywords:	allogeneic hematopoietic cell transplantation expanded access MDS myelodysplastic syndromes reduce intensity conditioning

设为首页 | 免责声明 | 关于勤云 | 加入收藏